United States Nuclear Imaging Market 2026 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities

Market Size and Growth

The Nuclear Imaging Market is expected grow at a CAGR of 12.9% during the forecast period 2024-2031

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/nuclear-imaging-market?sb

Key Development:

United States: Recent Industry Developments

✅ In February 2026, Telix Pharmaceuticals advanced its global clinical expansion by dosing the first patient in a Phase 3 study evaluating PSMA PET imaging for prostate cancer. The development strengthens progress in precision nuclear imaging diagnostics. It supports improved disease detection and clinical decision-making.

✅ In January 2026, Telix Pharmaceuticals reported continued momentum following strong adoption of its PSMA imaging agent portfolio in the U.S. The update highlighted commercial performance and infrastructure scaling initiatives. The progress reinforces supply reliability for nuclear imaging procedures.

✅ In December 2025, healthcare providers accelerated investments in compact and high-energy cyclotron systems to support onsite radioisotope production. The trend reflects growing demand for PET-based diagnostic imaging. It strengthens domestic nuclear imaging capabilities.

✅ In December 2025, adoption of PET imaging technologies expanded across oncology, cardiology, and neurology applications. Increased system installations supported higher diagnostic throughput. The development underscores sustained clinical integration of nuclear imaging.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=nuclear-imaging-market

Japan: Recent Industry Developments

✅ In February 2026, nuclear medicine centers in Japan continued expanding PET/SPECT imaging capabilities to support precision diagnostics. The upgrades focused on high-sensitivity hybrid imaging platforms. The shift enhances diagnostic accuracy and workflow efficiency.

✅ In January 2026, Japanese imaging providers strengthened investments in advanced radiopharmaceutical utilization and imaging technologies. The development supports rising demand for molecular imaging diagnostics. It reinforces modernization of nuclear imaging infrastructure.

✅ In December 2025, Japan's nuclear medicine sector saw increased deployment of hybrid imaging systems integrating PET technologies. The installations improved clinical diagnostic performance. The expansion supports advanced disease evaluation strategies.

✅ In December 2025, collaborations across industry and research institutions intensified to enhance cyclotron efficiency and isotope production systems. The initiatives aim to improve radiotracer availability. The progress supports Japan's growing nuclear imaging ecosystem.

Key Players:

=> Bracco Imaging SpA, Cardinal Health Inc., GE Healthcare, Koninklijke Philips NV, Siemens Healthineers, Curium, CMR NAVISCAN (GAMMA MEDICA INC.), Nordion (Canada) Inc., NTP Radioisotopes SOC, Canon Medical Systems Corporation among others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nuclear-imaging-market?sb

Key Segments:

By Product Type

Hybrid PET Systems dominate the market with 34% share, driven by their superior imaging precision, combined anatomical-functional capabilities, and rising adoption in oncology diagnostics. Their ability to deliver enhanced diagnostic accuracy continues to accelerate demand.

Standalone PET Systems account for 21%, supported by growing utilization in specialized imaging centers and expanding applications in neurological and cardiac assessments.

Hybrid SPECT Systems capture 24% share, benefiting from cost-efficiency advantages, expanding clinical applications, and improved diagnostic performance through integrated imaging technologies.

Standalone SPECT Systems hold 15%, reflecting stable demand across hospitals and diagnostic facilities due to their affordability and wide clinical utility.

Planar Scintigraphy represents 6% share, primarily used in routine diagnostic procedures and legacy installations.

By Application

Oncology leads the market with 48% share, fueled by increasing cancer prevalence, growing demand for early detection, and expanding use of hybrid imaging technologies for tumor localization and therapy monitoring.

Cardiology accounts for 27%, driven by rising cardiovascular disease burden and growing reliance on nuclear imaging for functional cardiac assessments.

Neurology captures 18% share, supported by increasing applications in neurodegenerative disorder diagnosis and brain function studies.

Others contribute 7%, including emerging clinical applications.

By End-User

Hospitals dominate with 45% share, supported by expanding imaging infrastructure, rising patient volumes, and growing integration of advanced diagnostic technologies.

Diagnostic Centres account for 28%, benefiting from increasing outpatient imaging demand and rising preference for specialized diagnostic services.

Research Centres capture 12% share, reflecting growing investments in molecular imaging and clinical research.

Academic Centres hold 9%, driven by expanding medical education and research initiatives.

Others represent 6%, including specialty clinics and private imaging facilities.

By Region

North America leads the global market with 37% share, driven by strong healthcare expenditure, rapid adoption of advanced imaging systems, and expanding nuclear medicine applications.

Europe accounts for 26%, supported by technological advancements, rising diagnostic demand, and favorable reimbursement frameworks.

Asia Pacific captures 24% share, reflecting rapid healthcare infrastructure development and increasing investments in diagnostic technologies.

Latin America holds 8%, supported by improving healthcare access.

Middle East & Africa represent 5%, driven by expanding medical imaging investments.

Outlook & Opportunity Analysis (2025-2033)

The nuclear medicine imaging systems market is expected to witness steady growth, driven by rising chronic disease prevalence, expanding applications of hybrid imaging technologies, and increasing healthcare investments. Key opportunities lie in hybrid imaging systems, AI-assisted diagnostics, and emerging markets expansion.

FAQ

Q: What is the growth rate of the Nuclear Imaging Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 12.9% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.